Novo Nordisk A/S: Novo Nordisk files annual report with the SEC

Bagsværd, Denmark, 5 February 2019 - Novo Nordisk A/S has filed its Annual Report 2018 on Form 20-F for the financial year 2018 with the US Securities and Exchange Commission (SEC), incorporating by reference parts of the Novo Nordisk A/S Annual Report 2018. The reports are available at the SEC's website, www.sec.gov (http://www.sec.gov/index.htm), as well as on novonordisk.com (http://www.novonordisk.com/annualreport).

Shareholders and ADR holders may receive a hard copy of the annual reports free of charge upon request by filling out a request form on novonordisk.com (http://www.novonordisk.com/annualreport) or upon request to [e-mail] (mailto:[e-mail]) - please state the exact mailing address and the document(s) you wish to receive.

Further information

Media:
Mette Kruse Danielsen	[phone]	[e-mail] (mailto:[e-mail])
Ken Inchausti (US)	[phone]	[e-mail] (mailto:[e-mail])
Investors:
Peter Hugreffe Ankersen	[phone]	[e-mail] (mailto:[e-mail])
Anders Mikkelsen	[phone]	[e-mail] (mailto:[e-mail])
Valdemar Borum Svarrer	[phone]	[e-mail] (mailto:[e-mail])
Kristoffer Due Berg	[phone]	[e-mail] (mailto:[e-mail])
Ann Søndermølle Rendbæk	[phone]	[e-mail] (mailto:[e-mail])

PR190205_filing of Annual Report_SEC_UK (http://hugin.info/2013/R/2233342/878498.pdf)

---

This announcement is distributed by West Corporation on behalf of West Corporation clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via Globenewswire